Rare diseases
Investigational molecules
Locations
North Block E 168 F 2, 218 Xinghu Road, Wuzhong, 215105
Clinical research activity is centered on unresectable advanced hepatocellular carcinoma, with interest in treatment options for advanced liver cancer that cannot be removed surgically.
The sponsor’s trial portfolio in this area reflects a focus on systemic treatment strategies for patients with advanced disease.
Cstone Pharmaceuticals (Suzhou) Co. Ltd. runs clinical trials in conditions such as Hepatocellular carcinoma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
